SCHEMBL3880853

SCHEMBL3880853

CCc1ccccc1-c1nc(N2CCOCC2)nc(N2CCN(c3ccccn3)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
HSD17B10 Q99714 5/20 0.50
KDM4E B2RXH2 5/20 0.50
HPGD P15428 3/20 0.50
PIK3CA P42336 6/20 0.48
MTOR P42345 6/20 0.48
MAPT P10636 3/20 0.47
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
DHFR P00374 1/20 0.43
PIK3R1 P27986 2/20 0.43
MAPK1 P28482 1/20 0.43
NPC1 O15118 1/20 0.42
HK1 P19367 1/20 0.42
RAB9A P51151 1/20 0.42
HKDC1 Q2TB90 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3878604 0.85 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3876033 0.82 HPGD (0.50) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3879980 0.82 CNR2 (0.51) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3879522 0.81 HSD17B10 (0.52) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3884243 0.81 PIK3CA (0.54) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3877480 0.80 PIK3CA (0.51) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL13761287 0.79 HTT (0.61) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3881883 0.79 PIK3CA (0.49) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3887124 0.79 HPGD (0.50) ALDH1A1HSD17B10KDM4EHPGDPIK3CA
SCHEMBL3877790 0.78 MEN1 (0.53) ALDH1A1HSD17B10KDM4EHPGDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues GPR174, GPR68, PPARG ALDH1A1 920/4885HSD17B10 3040/4885KDM4E 3890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.